Revelation Announces FR for the Three and Twelve Months Ended Dec/31/23
Revelation Biosciences Inc. Gives Oral Presentation
Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation
Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
Revelation Biosciences Inc. to Present at The International Conference
Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024
Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference
Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors
Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023